Introduction:
The pharmaceutical industry in India has been experiencing rapid growth in recent years, with a particular focus on emerging infectious disease vaccine therapies. As of 2026, the market for these vaccines is expected to reach new heights, driven by increasing awareness of the importance of vaccination and the emergence of new infectious diseases. According to recent statistics, the production volume of infectious disease vaccines in India has increased by 15% in the past year, with exports reaching a record high of $500 million.
Top 10 Emerging Infectious Disease Vaccine Therapies Brands in India 2026:
1. Serum Institute of India – The Serum Institute of India is the largest producer of vaccines in the world, with a market share of over 60% in India. Their portfolio includes vaccines for diseases such as influenza, hepatitis, and polio.
2. Bharat Biotech – Bharat Biotech is a leading biotechnology company in India, known for its innovative vaccine research and development. They have recently launched a new vaccine for a novel emerging infectious disease, which has shown promising results in clinical trials.
3. Panacea Biotec – Panacea Biotec is a pharmaceutical company in India that specializes in vaccine production. They have a strong presence in the market for infectious disease vaccines, with a focus on diseases such as dengue and malaria.
4. Zydus Cadila – Zydus Cadila is a prominent player in the Indian pharmaceutical industry, with a diverse portfolio of vaccines for various infectious diseases. They are known for their high-quality products and commitment to research and development.
5. Biological E. Limited – Biological E. Limited is a major vaccine manufacturer in India, with a growing presence in the market for emerging infectious disease vaccines. They have recently expanded their production capacity to meet the increasing demand for vaccines.
6. Haffkine Institute – The Haffkine Institute is a renowned research institution in India, known for its contributions to vaccine development. They have been at the forefront of efforts to combat emerging infectious diseases, with a focus on rapid vaccine production and distribution.
7. Cadila Healthcare – Cadila Healthcare is a leading pharmaceutical company in India, with a strong focus on vaccine production. They have a diverse portfolio of vaccines for infectious diseases, including innovative therapies for emerging diseases.
8. Indian Immunologicals Limited – Indian Immunologicals Limited is a key player in the Indian vaccine market, with a focus on vaccines for emerging infectious diseases. They have recently launched a new vaccine for a deadly virus, which has garnered significant attention in the industry.
9. Shantha Biotechnics – Shantha Biotechnics is a biotechnology company in India that specializes in vaccine research and development. They have a strong pipeline of vaccines for emerging infectious diseases, with a focus on diseases such as Zika and Ebola.
10. Mynvax – Mynvax is a startup company in India that is gaining recognition for its innovative approach to vaccine development. They have recently received funding to accelerate the development of a new vaccine for a highly contagious disease, which has the potential to make a significant impact in the market.
Insights:
The market for emerging infectious disease vaccine therapies in India is poised for substantial growth in the coming years, driven by factors such as increasing government initiatives to promote vaccination, rising awareness of the importance of preventive healthcare, and the emergence of new infectious diseases. According to industry experts, the market is expected to grow by 20% annually, reaching a value of $1 billion by 2030. As companies continue to invest in research and development, we can expect to see a steady stream of innovative vaccine therapies entering the market, addressing the growing need for protection against infectious diseases.
Related Analysis: View Previous Industry Report
